Mario Santinami

15.6k citations
189 papers · 12.4k · 3 hit papers · h-index 53

Impact in

  • Oncology top 0.2%
    • Cutaneous Melanoma Detection and Management
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers
  • Immunology top 0.5%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction

Papers in

    • Cutaneous Melanoma Detection and Management 91
    • CAR-T cell therapy research 23
    • Cancer Immunotherapy and Biomarkers 8
    • Immunotherapy and Immune Responses 33
    • T-cell and B-cell Immunology 7

Mario Santinami

186 papers receiving 12.0k citations

Mario Santinami's Hit Papers

Systemic Therapy for Melanoma: ASCO Guideline Update 2023 · 129 citations
1290+5+11Years since publication2505007501000

Peers

Mario Santinami
Comparison fields: 5 of 137
  • Oncology 7.2k
  • Immunology 3.2k
  • Cancer Research 1.5k
  • Molecular Biology 4.7k
  • Dermatology 444
Replace Yasodha Natkunam with:
Yasodha Natkunam United States
Alan Spatz France
Rajmohan Murali United States
Stanley P. L. Leong United States
Klaus Griewank Germany
Martin‐Leo Hansmann Germany
Andréas Mackensen Germany
Raymond L. Barnhill United States
Mary Susan Brady United States
Alexander Christopher Jonathan van Akkooi Netherlands
Mario Santinami relative to Yasodha Natkunam United States Yasodha Natkunam's profile →
Citations per field
00.5×1.5×
Yasodha Natkunam · 1×
Citations per year

Countries citing papers authored by Mario Santinami

Since Specialization
Citations

This map shows the geographic impact of Mario Santinami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Santinami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Santinami more than expected).

Fields of papers citing papers by Mario Santinami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Santinami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Santinami. The network helps show where Mario Santinami may publish in the future.

Co-authors

The 25 scholars most cited alongside Mario Santinami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mario Santinami Line = papers co-authored together Mario Santinami links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 189 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Adjuvant Dabrafenib plus Trametinib in Stage III BRAF -Mutated Melanoma
Hit paper breakdown →
20171143
2
High Levels of Exosomes Expressing CD63 and Caveolin-1 in Plasma of Melanoma Patients
Hit paper breakdown →
2009827
3 2012544
4 1998516
5 2008505
6 2007475
7 2020303
8 2003290
9 2009274
10 2000272
11 2006256
12 2012246
13 2009230
14 2012229
15 2020213
16 2001201
17 2018201
18 2003191
19 2005167
20 2004161

About Mario Santinami

Mario Santinami is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Genetics, having authored 189 papers that have together received 12.4k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (91 papers), Melanoma and MAPK Pathways (36 papers), Immunotherapy and Immune Responses (33 papers), CAR-T cell therapy research (23 papers), Sarcoma Diagnosis and Treatment (16 papers), Virus-based gene therapy research (11 papers), Cancer Immunotherapy and Biomarkers (8 papers) and T-cell and B-cell Immunology (7 papers). The work is most often cited by research in Oncology (7.2k citations), Immunology (3.2k citations), Cancer Research (1.5k citations), Molecular Biology (4.7k citations) and Dermatology (444 citations). Mario Santinami has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Filiberto Belli, Licia Rivoltini, N. Cascinelli, Alberto Morabito, Giorgio Parmiani, Alessandro Testori, Natale Cascinelli, RM MacKie, Andrea Maurichi and Roberto Patuzzo. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Melanoma Research and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact